ALLMedicine™ Graves Disease Center

Mar 16th, 2023 - To describe the incidence, risk factors, and outcomes of incident atrial fibrillation (AF) in Graves disease (GD). Patients with GD between January 1, 2009, and December 31, 2019, were included retrospectively. We defined GD-related AF as AF diagn...

Feb 16th, 2023 - BACKGROUND Tocilizumab is a therapeutic biologic antagonist of the interleukin-6 (IL-6) receptor that has been approved to treat some autoimmune and chronic inflammatory diseases. This report is of a patient with a history of Graves disease and se...

Feb 7th, 2023 - Practice Essentials Hürthle cell carcinoma of the thyroid gland is an unusual and relatively rare type of differentiated thyroid cancer.[1] Hürthle cell cancer accounts for only about 3-10% of all differentiated thyroid cancers; therefore, few ins...

Feb 7th, 2023 - Practice Essentials Hürthle cell carcinoma of the thyroid gland is an unusual and relatively rare type of differentiated thyroid cancer. [1] Hürthle cell cancer accounts for only about 3-10% of all differentiated thyroid cancers; therefore, few in...

Feb 7th, 2023 - Practice Essentials Hürthle cell carcinoma of the thyroid gland is an unusual and relatively rare type of differentiated thyroid cancer. [1] Hürthle cell cancer accounts for only about 3-10% of all differentiated thyroid cancers; therefore, few in...

Jan 10th, 2023 - Mental fatigue occurs in many diseases and the reasons are mostly unknown. The investigators hypothesize that remaining mental fatigue after restored hyperthyroidism in Graves' disease is an autoimmune complication. The aim of this study is to exp...

Dec 12th, 2022 - Hyperthyroidism is a clinical syndrome caused by increased thyroid hormone in the blood, it can lead to multiple complications, including cardiac, hepatic, and hematologic system complications. More than 80% of hyperthyroidism are caused by Graves...

Sep 8th, 2022 - Project basis: Thyroid-associated ophthalmopathy (GO), a vision-threatening autoimmune disease, is the most common extrathyroidal manifestation of Graves disease. At present, GO treatment is still dominated by hormone therapy. From 2010 to 2018, t...

Sep 14th, 2021 - Graves' disease is the main cause of clinically hyperthyroidism, accounting for about 75% to 80%, and it occurs in women of childbearing age. Clinical manifestations include: high eating, weight loss, sweating, palpitations, emotional excitement a...

Apr 20th, 2021 - Background: Tremelimumab is a monoclonal antibody against cytotoxic T-lymphocyte-associated protein 4 (CTLA4). Anti-CTLA4 therapy has been shown to enhance anti-tumor immunity by blocking tumor-induced immune suppression of cytotoxic T cells. Durv...

Nov 3rd, 2022 - The study covered in this summary was published on Research Square as a preprint has not yet been peer reviewed. Key Takeaway Among women with hypoparathyroidism, bone mineral density (BMD) was increased, and there was no increase in fracture risk...

Aug 4th, 2022 - The major classifications of thyroid disease include hyperthyroidism, which is seen in Graves disease, and hypothyroidism due to iodine deficiency and Hashimoto thyroiditis, which have potentially devastating health consequences. The prevalence of.

Jul 7th, 2022 - This transcript has been edited for clarity. Angela Leung, MD, MSc: Welcome to this video commentary about the long-term use of antithyroid drugs in the management of Graves disease. My name is Angela Leung. I'm an adult endocrinologist at the Uni...

Apr 21st, 2022 - Matthew I. Balcerek, BExSci, MBBS COVID-19 has caused disease in close to 500 million people worldwide, according to the World Health Organization. While the airways are its primary target, SARS-CoV-2 may enter many organs via the protein angioten...

Feb 23rd, 2022 - To the Editor: Pretibial myxedema (PTM) is bilateral, nonpitting, scaly thickening and induration of the skin that most commonly occurs on the anterior aspects of the legs and feet. Pretibial myxedema occurs in approximately 0.